Pharmacological intervention in antibody mediated disease

Lupus

Volumn 5, Issue 2, 1996, Pages 158-159

  Coutts, S M ^a   Plunkett, M L ^a   Iverson, G M ^a   Barstad, P A ^a   Berner, C M ^a  

^a La Jolla Pharmaceutical Company   (United States)

Author keywords

Anti dsDNA; Antibody; Antibody mediated disease; B cells; LJP 394; Lupus; Systemic lupus erythematosus (SLE); Tolerance

Indexed keywords

ABETIMUS; AUTOANTIBODY; DNA ANTIBODY; EPITOPE; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; B LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; CROSS LINKING; IMMUNOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

EID: 0029995138     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500214     Document Type: Conference Paper

References (13)

1. Goodnow CC et al. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 1989; 342: 385-391.
2. Fulcher DA, Basten, A. Reduced lifespan of anergic self-reactive B cells in a double transgenic model. J Exp Med 1994; 179: 125-134.
3. Rammensee HG, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995; 41: 178-228.
4. Parry S, Hasbold J, Holman M, Klaus GB. Hypercross-linking of surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol 1994; 152: 2821-2829.
5. Finkelman FD, Holmes JM, Dukhanina OI, Morris SC. Cross linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J Exp Med 1995; 181: 515-525.
6. Lambert PH, Dixon FJ. Pathogenesis of the glomerulonephritis of NZB/NZW mice. J Exp Med 1968; 127: 507-521.
7. Hahn B, Ebling FM. Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA. J Immunol 1984; 132: 187-190.
8. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci, USA 1990; 87: 4120-4124.
9. Matsuura E et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992; 148: 3885-3891.
10. Lindstrom J, Shelton D, Fujii Y. Myasthenia gravis. Adv Immunol 1988; 42: 233-284.
11. Marion S, Braun JM, Ropars A, Kohn LD, Charreire J. Induction of autoimmunity by immunization of mice with human thyrotropin receptor. Cell Immunol 1994; 158: 329-341.
12. Moise, KJ Jr. Management of red cell alloimmunization in pregnancy. In RA Sacher and ME Brecher (eds) Obstetric Transfusion Practice. Bethesda, MD: American Association of Blood Banks, 1993; 21-46.
13. Jones DS et al. Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP 394), a therapeutic candidate for the treatment of lupus nephritis. J Med Chem 1995; 38: 2138-2144.